Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 115

1.

LONG-TERM SURVIVAL OF PSEUDOGYMNOASCUS DESTRUCTANS AT ELEVATED TEMPERATURES.

Campbell LJ, Walsh DP, Blehert DS, Lorch JM.

J Wildl Dis. 2019 Oct 17. [Epub ahead of print]

PMID:
31622188
2.

Ketogenic diet combined with antioxidant N-acetylcysteine inhibits tumor growth in a mouse model of anaplastic thyroid cancer.

Aggarwal A, Yuan Z, Barletta JA, Lorch JH, Nehs MA.

Surgery. 2019 Sep 11. pii: S0039-6060(19)30458-1. doi: 10.1016/j.surg.2019.06.042. [Epub ahead of print]

PMID:
31521320
3.

Prognostic Significance of Extent of Invasion in Poorly Differentiated Thyroid Carcinoma.

Wong KS, Lorch JH, Alexander EK, Marqusee E, Cho NL, Nehs MA, Doherty GM, Barletta JA.

Thyroid. 2019 Sep;29(9):1255-1261. doi: 10.1089/thy.2019.0263.

PMID:
31397224
4.

A novel host-adapted strain of Salmonella Typhimurium causes renal disease in olive ridley turtles (Lepidochelys olivacea) in the Pacific.

Work TM, Dagenais J, Stacy BA, Ladner JT, Lorch JM, Balazs GH, Barquero-Calvo E, Berlowski-Zier BM, Breeden R, Corrales-Gómez N, Gonzalez-Barrientos R, Harris HS, Hernández-Mora G, Herrera-Ulloa Á, Hesami S, Jones TT, Morales JA, Norton TM, Rameyer RA, Taylor DR, Waltzek TB.

Sci Rep. 2019 Jun 27;9(1):9313. doi: 10.1038/s41598-019-45752-5.

5.

Virally-vectored vaccine candidates against white-nose syndrome induce anti-fungal immune response in little brown bats (Myotis lucifugus).

Rocke TE, Kingstad-Bakke B, Wüthrich M, Stading B, Abbott RC, Isidoro-Ayza M, Dobson HE, Dos Santos Dias L, Galles K, Lankton JS, Falendysz EA, Lorch JM, Fites JS, Lopera-Madrid J, White JP, Klein B, Osorio JE.

Sci Rep. 2019 May 1;9(1):6788. doi: 10.1038/s41598-019-43210-w.

6.

The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer.

Silva de Morais N, Stuart J, Guan H, Wang Z, Cibas ES, Frates MC, Benson CB, Cho NL, Nehs MA, Alexander CA, Marqusee E, Kim MI, Lorch JH, Barletta JA, Angell TE, Alexander EK.

J Endocr Soc. 2019 Mar 5;3(4):791-800. doi: 10.1210/js.2018-00427. eCollection 2019 Apr 1.

7.

Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.

Kacew AJ, Harris EJ, Lorch JH, Haddad RI, Chau NG, Rabinowits G, LeBoeuf NR, Schmults CD, Thakuria M, MacConaill LE, Hanna GJ.

Eur J Cancer. 2019 May;113:1-9. doi: 10.1016/j.ejca.2019.03.004. Epub 2019 Apr 4.

PMID:
30954880
8.

Mortality due to Tyzzer's Disease of Muskrats (Ondatra zibethicus) in Northern Ohio, USA.

Grear DA, Lankton JS, Zaleski S, Witt M, Lorch JM.

J Wildl Dis. 2019 Oct;55(4):982-985. Epub 2019 Apr 3.

PMID:
30943097
9.

Evidence of Vertical Transmission of the Snake Fungal Pathogen Ophidiomyces ophiodiicola.

Stengle AG, Farrell TM, Freitas KS, Lind CM, Price SJ, Butler BO, Tadevosyan T, Isidoro-Ayza M, Taylor DR, Winzeler M, Lorch JM.

J Wildl Dis. 2019 Oct;55(4):961-964. Epub 2019 Mar 21.

PMID:
30896366
10.

Clinicopathologic Features of Mismatch Repair-Deficient Anaplastic Thyroid Carcinomas.

Wong KS, Lorch JH, Alexander EK, Nehs MA, Nowak JA, Hornick JL, Barletta JA.

Thyroid. 2019 May;29(5):666-673. doi: 10.1089/thy.2018.0716. Epub 2019 Apr 16.

PMID:
30869569
11.

Everolimus in Anaplastic Thyroid Cancer: A Case Series.

Harris EJ, Hanna GJ, Chau N, Rabinowits G, Haddad R, Margalit DN, Schoenfeld J, Tishler RB, Barletta JA, Nehs M, Janne P, Huang J, Groden P, Kacew A, Lorch J.

Front Oncol. 2019 Feb 26;9:106. doi: 10.3389/fonc.2019.00106. eCollection 2019.

12.

Malassezia vespertilionis sp. nov.: a new cold-tolerant species of yeast isolated from bats.

Lorch JM, Palmer JM, Vanderwolf KJ, Schmidt KZ, Verant ML, Weller TJ, Blehert DS.

Persoonia. 2018 Dec;41:56-70. doi: 10.3767/persoonia.2018.41.04. Epub 2018 Feb 5.

13.

IMRT-based treatment of unknown primary malignancy of the head and neck: Outcomes and improved toxicity with decreased mucosal dose and larynx sparing.

LaVigne AW, Margalit DN, Rawal B, Puzanov M, Annino DJ, Goguen LA, Sher DJ, Schoenfeld JD, Chau NG, Lorch JH, Rabinowits G, Haddad RI, Tishler RB.

Head Neck. 2019 Apr;41(4):959-966. doi: 10.1002/hed.25531. Epub 2019 Jan 8.

PMID:
30620435
14.

Field Diagnostics and Seasonality of Ophidiomyces ophiodiicola in Wild Snake Populations.

McKenzie JM, Price SJ, Fleckenstein JL, Drayer AN, Connette GM, Bohuski E, Lorch JM.

Ecohealth. 2019 Mar;16(1):141-150. doi: 10.1007/s10393-018-1384-8. Epub 2018 Oct 22.

PMID:
30349999
15.

Radiologic predictors of immune checkpoint inhibitor response in advanced head and neck squamous cell carcinoma.

Sridharan V, Rahman RM, Huang RY, Chau NG, Lorch JH, Uppaluri R, Haddad RI, Hanna GJ, Schoenfeld JD.

Oral Oncol. 2018 Oct;85:29-34. doi: 10.1016/j.oraloncology.2018.08.005. Epub 2018 Aug 17.

PMID:
30220316
16.

Mortality of Little Brown Bats ( Myotis lucifugus carissima) Naturally Exposed to Microcystin-LR.

Isidoro-Ayza M, Jones L, Dusek RJ, Lorch JM, Landsberg JH, Wilson P, Graham S.

J Wildl Dis. 2019 Jan;55(1):266-269. doi: 10.7589/2018-02-047. Epub 2018 Sep 14.

PMID:
30216129
17.

Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer.

Hanna GJ, Kacew A, Chau NG, Shivdasani P, Lorch JH, Uppaluri R, Haddad RI, MacConaill LE.

JCI Insight. 2018 Sep 6;3(17). pii: 122799. doi: 10.1172/jci.insight.122799. eCollection 2018 Sep 6.

18.

Detection of Bisgaard Taxon 40 in Rhinoceros Auklets ( Cerorhinca monocerata) with Pneumonia and Septicemia from a Mortality Event in Washington, USA.

Knowles S, Bodenstein BL, Berlowski-Zier BM, Thomas SM, Pearson SF, Lorch JM.

J Wildl Dis. 2019 Jan;55(1):246-249. doi: 10.7589/2017-12-309. Epub 2018 Aug 10.

PMID:
30096034
19.

Inconsistent HIV reservoir dynamics and immune responses following anti-PD-1 therapy in cancer patients with HIV infection.

Scully EP, Rutishauser RL, Simoneau CR, Delagrèverie H, Euler Z, Thanh C, Li JZ, Hartig H, Bakkour S, Busch M, Alter G, Marty FM, Wang CC, Deeks SG, Lorch J, Henrich TJ.

Ann Oncol. 2018 Oct 1;29(10):2141-2142. doi: 10.1093/annonc/mdy259. No abstract available.

20.

Mass Mortality of Green Frog ( Rana clamitans) Tadpoles in Wisconsin, USA, Associated with Severe Infection with the Pathogenic Perkinsea Clade.

Isidoro-Ayza M, Lorch JM, Ballmann AE, Businga NK.

J Wildl Dis. 2019 Jan;55(1):262-265. doi: 10.7589/2018-02-046. Epub 2018 Jul 19.

PMID:
30024771
21.

Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.

Schoenfeld JD, Gjini E, Rodig SJ, Tishler RB, Rawal B, Catalano PJ, Uppaluri R, Haddad RI, Hanna GJ, Chau NG, Rabinowits G, Lorch J, Jo VY, Krane JF, Goguen LA, Annino DJ, Abdelrahman S, Lipschitz M, Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):137-145. doi: 10.1016/j.ijrobp.2018.05.002. Epub 2018 Jun 29.

PMID:
29960819
22.

Lenvatinib-Associated Cervical Artery Dissections in a Patient with Radioiodine-Refractory Metastatic Papillary Thyroid Carcinoma.

Groden PJ, Lee TC, Bhattacharyya S, Connors J, Lorch J.

Front Med (Lausanne). 2018 Feb 23;4:220. doi: 10.3389/fmed.2017.00220. eCollection 2017.

23.

Frameshift events predict anti-PD-1/L1 response in head and neck cancer.

Hanna GJ, Lizotte P, Cavanaugh M, Kuo FC, Shivdasani P, Frieden A, Chau NG, Schoenfeld JD, Lorch JH, Uppaluri R, MacConaill LE, Haddad RI.

JCI Insight. 2018 Feb 22;3(4). pii: 98811. doi: 10.1172/jci.insight.98811. eCollection 2018 Feb 22.

24.

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.

Kaufman HL, Russell JS, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Milella M, Brownell I, Lewis KD, Lorch JH, von Heydebreck A, Hennessy M, Nghiem P.

J Immunother Cancer. 2018 Jan 19;6(1):7. doi: 10.1186/s40425-017-0310-x.

25.

Genomic Correlates of Response to Everolimus in Aggressive Radioiodine-refractory Thyroid Cancer: A Phase II Study.

Hanna GJ, Busaidy NL, Chau NG, Wirth LJ, Barletta JA, Calles A, Haddad RI, Kraft S, Cabanillas ME, Rabinowits G, O'Neill A, Limaye SA, Alexander EK, Moore FD Jr, Misiwkeiwicz K, Thomas T, Nehs M, Marqusee E, Lee SL, Jänne PA, Lorch JH.

Clin Cancer Res. 2018 Apr 1;24(7):1546-1553. doi: 10.1158/1078-0432.CCR-17-2297. Epub 2018 Jan 4.

26.

Host susceptibility to snake fungal disease is highly dispersed across phylogenetic and functional trait space.

Burbrink FT, Lorch JM, Lips KR.

Sci Adv. 2017 Dec 20;3(12):e1701387. doi: 10.1126/sciadv.1701387. eCollection 2017 Dec.

27.

Patterns of Circulating Corticosterone in a Population of Rattlesnakes Afflicted with Snake Fungal Disease: Stress Hormones as a Potential Mediator of Seasonal Cycles in Disease Severity and Outcomes.

Lind C, Moore IT, Akçay Ç, Vernasco BJ, Lorch JM, Farrell TM.

Physiol Biochem Zool. 2018 Mar/Apr;91(2):765-775. doi: 10.1086/695747.

PMID:
29286254
28.

Phylogenetics of a Fungal Invasion: Origins and Widespread Dispersal of White-Nose Syndrome.

Drees KP, Lorch JM, Puechmaille SJ, Parise KL, Wibbelt G, Hoyt JR, Sun K, Jargalsaikhan A, Dalannast M, Palmer JM, Lindner DL, Marm Kilpatrick A, Pearson T, Keim PS, Blehert DS, Foster JT.

MBio. 2017 Dec 12;8(6). pii: e01941-17. doi: 10.1128/mBio.01941-17.

29.

CDK4/6 Inhibition Augments Antitumor Immunity by Enhancing T-cell Activation.

Deng J, Wang ES, Jenkins RW, Li S, Dries R, Yates K, Chhabra S, Huang W, Liu H, Aref AR, Ivanova E, Paweletz CP, Bowden M, Zhou CW, Herter-Sprie GS, Sorrentino JA, Bisi JE, Lizotte PH, Merlino AA, Quinn MM, Bufe LE, Yang A, Zhang Y, Zhang H, Gao P, Chen T, Cavanaugh ME, Rode AJ, Haines E, Roberts PJ, Strum JC, Richards WG, Lorch JH, Parangi S, Gunda V, Boland GM, Bueno R, Palakurthi S, Freeman GJ, Ritz J, Haining WN, Sharpless NE, Arthanari H, Shapiro GI, Barbie DA, Gray NS, Wong KK.

Cancer Discov. 2018 Feb;8(2):216-233. doi: 10.1158/2159-8290.CD-17-0915. Epub 2017 Nov 3.

30.

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

Jenkins RW, Aref AR, Lizotte PH, Ivanova E, Stinson S, Zhou CW, Bowden M, Deng J, Liu H, Miao D, He MX, Walker W, Zhang G, Tian T, Cheng C, Wei Z, Palakurthi S, Bittinger M, Vitzthum H, Kim JW, Merlino A, Quinn M, Venkataramani C, Kaplan JA, Portell A, Gokhale PC, Phillips B, Smart A, Rotem A, Jones RE, Keogh L, Anguiano M, Stapleton L, Jia Z, Barzily-Rokni M, Cañadas I, Thai TC, Hammond MR, Vlahos R, Wang ES, Zhang H, Li S, Hanna GJ, Huang W, Hoang MP, Piris A, Eliane JP, Stemmer-Rachamimov AO, Cameron L, Su MJ, Shah P, Izar B, Thakuria M, LeBoeuf NR, Rabinowits G, Gunda V, Parangi S, Cleary JM, Miller BC, Kitajima S, Thummalapalli R, Miao B, Barbie TU, Sivathanu V, Wong J, Richards WG, Bueno R, Yoon CH, Miret J, Herlyn M, Garraway LA, Van Allen EM, Freeman GJ, Kirschmeier PT, Lorch JH, Ott PA, Hodi FS, Flaherty KT, Kamm RD, Boland GM, Wong KK, Dornan D, Paweletz CP, Barbie DA.

Cancer Discov. 2018 Feb;8(2):196-215. doi: 10.1158/2159-8290.CD-17-0833. Epub 2017 Nov 3.

31.

NOVEL DERMATOPHILOSIS AND CONCURRENT AMYLOIDOSIS IN SANDERLINGS ( CALIDRIS ALBA) FROM LOUISIANA, USA.

Shearn-Bochsler V, Schulz JL, Dobbs RC, Lorch JM, Waddle JH, Grear DA.

J Wildl Dis. 2018 Jan;54(1):189-192. doi: 10.7589/2017-04-078. Epub 2017 Oct 31.

PMID:
29087775
32.

Tumor PD-L1 expression is associated with improved survival and lower recurrence risk in young women with oral cavity squamous cell carcinoma.

Hanna GJ, Woo SB, Li YY, Barletta JA, Hammerman PS, Lorch JH.

Int J Oral Maxillofac Surg. 2018 May;47(5):568-577. doi: 10.1016/j.ijom.2017.09.006. Epub 2017 Sep 29.

PMID:
28969885
33.

Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.

Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, Chau NG, Rabinowits G, Lorch JH, Annino DJ, Tishler RB.

Oral Oncol. 2017 Oct;73:160-165. doi: 10.1016/j.oraloncology.2017.08.012. Epub 2017 Sep 8.

PMID:
28939070
34.

Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer.

Rabinowits G, Bowden M, Flores LM, Verselis S, Vergara V, Jo VY, Chau N, Lorch J, Hammerman PS, Thomas T, Goguen LA, Annino D, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI.

Front Oncol. 2017 Aug 29;7:191. doi: 10.3389/fonc.2017.00191. eCollection 2017.

35.

Pathogenic lineage of Perkinsea associated with mass mortality of frogs across the United States.

Isidoro-Ayza M, Lorch JM, Grear DA, Winzeler M, Calhoun DL, Barichivich WJ.

Sci Rep. 2017 Aug 31;7(1):10288. doi: 10.1038/s41598-017-10456-1.

36.

Emerging fungal pathogen Ophidiomyces ophiodiicola in wild European snakes.

Franklinos LHV, Lorch JM, Bohuski E, Rodriguez-Ramos Fernandez J, Wright ON, Fitzpatrick L, Petrovan S, Durrant C, Linton C, Baláž V, Cunningham AA, Lawson B.

Sci Rep. 2017 Jun 19;7(1):3844. doi: 10.1038/s41598-017-03352-1.

37.

A case of primary secretory carcinoma of the thyroid with high-grade features.

Wu EY, Lebastchi J, Marqusee E, Lorch JH, Krane JF, Barletta JA.

Histopathology. 2017 Oct;71(4):665-669. doi: 10.1111/his.13268. Epub 2017 Jul 13. No abstract available.

38.

Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.

Hanna GJ, Sridharan V, Margalit DN, La Follette SK, Chau NG, Rabinowits G, Lorch JH, Haddad RI, Tishler RB, Anderson KS, Schoenfeld JD.

Cancer Biomark. 2017;19(2):129-136. doi: 10.3233/CBM-160071.

PMID:
28387659
39.

Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.

Zhang Y, Waterboer T, Haddad RI, Miles BA, Wentz A, Gross ND, Fakhry C, Quon H, Lorch JH, Gourin CG, Clayburgh D, Misiukiewicz KJ, Richmon JD, Andersen PE, Posner MR, D'Souza G.

Oral Oncol. 2017 Apr;67:77-82. doi: 10.1016/j.oraloncology.2017.02.004. Epub 2017 Feb 15.

40.

Defining an inflamed tumor immunophenotype in recurrent, metastatic squamous cell carcinoma of the head and neck.

Hanna GJ, Liu H, Jones RE, Bacay AF, Lizotte PH, Ivanova EV, Bittinger MA, Cavanaugh ME, Rode AJ, Schoenfeld JD, Chau NG, Haddad RI, Lorch JH, Wong KK, Uppaluri R, Hammerman PS.

Oral Oncol. 2017 Apr;67:61-69. doi: 10.1016/j.oraloncology.2017.02.005. Epub 2017 Feb 14.

PMID:
28351582
41.

Epstein-Barr virus-specific adoptive immunotherapy for recurrent, metastatic nasopharyngeal carcinoma.

Huang J, Fogg M, Wirth LJ, Daley H, Ritz J, Posner MR, Wang FC, Lorch JH.

Cancer. 2017 Jul 15;123(14):2642-2650. doi: 10.1002/cncr.30541. Epub 2017 Feb 21.

42.

Snake fungal disease: an emerging threat to wild snakes.

Lorch JM, Knowles S, Lankton JS, Michell K, Edwards JL, Kapfer JM, Staffen RA, Wild ER, Schmidt KZ, Ballmann AE, Blodgett D, Farrell TM, Glorioso BM, Last LA, Price SJ, Schuler KL, Smith CE, Wellehan JF Jr, Blehert DS.

Philos Trans R Soc Lond B Biol Sci. 2016 Dec 5;371(1709). pii: 20150457. doi: 10.1098/rstb.2015.0457. Review.

43.

Genomic Heterogeneity and Exceptional Response to Dual Pathway Inhibition in Anaplastic Thyroid Cancer.

Gibson WJ, Ruan DT, Paulson VA, Barletta JA, Hanna GJ, Kraft S, Calles A, Nehs MA, Moore FD Jr, Taylor-Weiner A, Wala JA, Zack TI, Lee TC, Fennessy FM, Alexander EK, Thomas T, Janne PA, Garraway LA, Carter SL, Beroukhim R, Lorch JH, Van Allen EM.

Clin Cancer Res. 2017 May 1;23(9):2367-2373. doi: 10.1158/1078-0432.CCR-16-2154-T. Epub 2016 Oct 17.

44.

Successful Management of a Patient with Malignant Thyroid Teratoma.

Rabinowits G, Barletta J, Sholl LM, Reche E, Lorch J, Goguen L.

Thyroid. 2017 Jan;27(1):125-128. doi: 10.1089/thy.2016.0201. Epub 2016 Nov 28.

PMID:
27784193
45.

Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.

Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, Limaye SA, Lorch JH, Lavigne AW, Schoenfeld JD, Sher DJ, Tishler RB.

Oral Oncol. 2016 Oct;61:19-26. doi: 10.1016/j.oraloncology.2016.07.012. Epub 2016 Aug 6.

PMID:
27688100
46.

Detection of spring viraemia of carp virus in imported amphibians reveals an unanticipated foreign animal disease threat.

Ip HS, Lorch JM, Blehert DS.

Emerg Microbes Infect. 2016 Sep 7;5(9):e97. doi: 10.1038/emi.2016.94.

47.

Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial.

Kaufman HL, Russell J, Hamid O, Bhatia S, Terheyden P, D'Angelo SP, Shih KC, Lebbé C, Linette GP, Milella M, Brownell I, Lewis KD, Lorch JH, Chin K, Mahnke L, von Heydebreck A, Cuillerot JM, Nghiem P.

Lancet Oncol. 2016 Oct;17(10):1374-1385. doi: 10.1016/S1470-2045(16)30364-3. Epub 2016 Sep 1.

48.

Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.

Lu W, Wayne PM, Davis RB, Buring JE, Li H, Macklin EA, Lorch JH, Burke E, Haddad TC, Goguen LA, Rosenthal DS, Tishler RB, Posner MR, Haddad RI.

Oncologist. 2016 Dec;21(12):1522-1529. Epub 2016 Aug 10.

49.

First Detection of Bat White-Nose Syndrome in Western North America.

Lorch JM, Palmer JM, Lindner DL, Ballmann AE, George KG, Griffin K, Knowles S, Huckabee JR, Haman KH, Anderson CD, Becker PA, Buchanan JB, Foster JT, Blehert DS.

mSphere. 2016 Aug 3;1(4). pii: e00148-16. doi: 10.1128/mSphere.00148-16. eCollection 2016 Jul-Aug.

50.

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.

Sridharan V, Margalit DN, Lynch SA, Severgnini M, Zhou J, Chau NG, Rabinowits G, Lorch JH, Hammerman PS, Hodi FS, Haddad RI, Tishler RB, Schoenfeld JD.

Br J Cancer. 2016 Jul 12;115(2):252-60. doi: 10.1038/bjc.2016.166. Epub 2016 Jul 5.

Supplemental Content

Support Center